Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Cancer genomics: The impact of genomic advances in oncology' returned 67 results - Page 1 of 4  FEATURED RESULTS Cancer Diagnostic Testing World Markets Antibody Drug Target Atlas in Oncology Drug Delivery in Cancer - Technologies, Markets and Companies Pharmacogenetics of Breast Cancer: Towards the Individualiza... Aurora Kinase inhibitors - The dawn of a new approach to cancer   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Advancing Molecular Diagnostics to Personalize Cancer Therapy   Business Insights, June 2011, Pages: 187 , colorectal, prostate, lung, and renal cancer. Highlights Advances in genomics, proteomics, molecular imaging, and other new technologies are leading to a molecularly based reclassification of malignancy Innovations in Oncology Diagnostics: Technological Advances, Growth Opportunities and Future Market Outlook   Business Insights, Oct 2009, Pages: 141 need such as ovarian cancer and colorectal cancer. Key benefits of this report - Understand the latest innovations in the oncology diagnostics market in the core areas – diagnostic imaging, molecular Molecular Diagnostics - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 1029 of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip and nanobiotechnology are expected to make a significant contribution to the growth of molecular diagnostics Biomarkers - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 864 of cancer Cancer Genome Atlas Cancer Genetic Markers of Susceptibility Project Oncology Biomarker Qualification Initiative Role of NCI in cancer biomarker development and validation Projects for cancer Enabling Oncology Diagnostics: Predictive Biomarkers Based on Genes, Proteins, and Pathways   Decision Resources, Inc., Dec 2008, Pages: 33 ER/PR Status Overexpression of HER2 KRAS Mutations Consortia for Advancing Cancer Biomarker Research Oncology Biomarker Qualifi cation Initiative The Biomarkers Consortium International Cancer Molecular Diagnostics in Cancer Testing   TriMark Publications, July 2011, Pages: 214 Hundreds of Genes 4.1.3.3 Employ Advanced Information Technology 4.2 Breast Cancer 4.2.1 Cancer Prognostic Assays 4.2.1.1 Myriad Genetics (BRACA1 and BRACA2) 4.2.1.2 Genomic Health (Oncotype DX) 4 Dealmaking and Industry Outlook: Targeted Cancer Therapies   Decision Resources, Inc., Dec 2009, Pages: 38 , cost-effectiveness, healthcare reform impact, patient drug assistant programs. Executive Summary Strategic Considerations Stakeholder Implications No Cure Yet Overall Oncology Market Cancer Commercializing Apoptotic Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others   Bioseeker, Dec 2011, Pages: 1617 .2.52 Ubiquitin-specific Protease Activity Targets 6.2.53 Other Targets 6.3 The Cancer Genome Project and Targets of Apoptotic Drugs in Oncology 6.3.1 Targets of Apoptotic Drugs in Oncology Present Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others   Bioseeker, Nov 2011, Pages: 906 Activity Targets 6.2.41 Other Targets 6.3 The Cancer Genome Project and Targets of Peptide Drugs in Oncology 6.3.1 Targets of Peptide Drugs in Oncology Present in the Cancer Gene Census Apoptotic Therapeutics in Oncology - Where to Commercialize?   Bioseeker, Nov 2009, Pages: 803 Apoptotic Drug Pipeline in Oncology and Competitive Fall-Out Table 248: ZymoGenetics’ Included Apoptotic Drug Pipeline in Oncology and Competitive Fall-Out - Abbott - AbGenomics - Access - Advanced Life Personalized Medicine 2010   Arrowhead Publishers, May 2010, Pages: 261 PERSONALIZED MEDICINE THERAPEUTICS 10.1 INTRODUCTION TO PERSONALIZED MEDICINE THERAPEUTICS 10.2 ONCOLOGY PERSONALIZED MEDICINE THERAPEUTICS 10.3 LUNG CANCER 10.3.1 OSI Pharmaceuticals/ Roche’s Tarceva Innovations in Diagnostics: Next Generation Molecular and Point-of-Care Diagnostics Driving Personalized Healthcare   Business Insights, Sep 2006, Pages: 126 The global diagnostics market is undergoing radical change; novel technologies driven by miniaturization and advances in genomics will enhance the role of diagnostics in the healthcare Commercializing Cancer Drugs Affecting Angiogenesis: A Decision Support Tool for Optimizing the Pipeline   Bioseeker, Sep 2010, Pages: 1227 Activity Targets 6.3 The Cancer Genome Project and Targets of Cancer Drugs Affecting Angiogenesis 6.3.1 Targets of Angiogenesis Affecting Drugs in Oncology Present in the Cancer Gene Census What Is the Future Role of Predictive Safety Biomarkers in Drug Development?   Decision Resources, Inc., Dec 2008, Pages: 39 biomarkers to select patients for non-small-cell lung cancer and colorectal cancer therapies. - Future role of predictive biomarkers: impact of KRAS gene, use of FDA guidance, and generating interest Molecular Cytogenetics - Global Strategic Business Report   Global Industry Analysts, Inc., Aug 2011, Pages: 239 Quantum Dot-Conjugates-FISH 5 Array-based Technology 5 Microarrays in Comparative Genomic Hybridization 5 2. INDUSTRY OVERVIEW 7 Advances in Molecular Biology Techniques Broaden the Scope Polymerase Chain Reaction (PCR): Products/Tools - A Global Market Watch, 2009-2015   Axis Research Mind, Nov 2011, Pages: 342 Expression Platform. Transgenomic, Inc. Signs An Agreement With Dana-Farber Cancer Institute For Cold-Pcr Technology. A Brand-New Workstation For Pcr By Hoefer, Inc. A New Genomic Analysis Tools Launched Biorepositories: Applications & Technologies - A Global Market Watch, 2009-2015   Axis Research Mind, Nov 2011, Pages: 730 & technologies areas discussed in the report are: BY APPLICATIONS Stem Cells Blood Products Human (Tissue Sections, Brain, Liver, Eyes, Heart, Kidney and Others) Veterinary Advanced Applications - Genomics (DNA Biorepositories: Applications & End-Users - A Global Market Watch, 2009-2015   Axis Research Mind, Nov 2011, Pages: 730 OF CRYOXTRACT'S NOVEL ROBOTIC TECHNOLOGY AT LABAUTOMATION 2009 DATAWORKS DEVELOPMENT INTRODUCES FREEZERWORKS UL 4.0 DECODE LAUNCHES DECODEME CARDIO™ AND DECODEME CANCER™ BIOCISION'S ADVANCED TEMPERATURE Biorepositories: Applications & Ownership - A Global Market Watch, 2009-2015   Axis Research Mind, Nov 2011, Pages: 771 are: BY APPLICATIONS Stem Cells Blood Products Human (Tissue Sections, Brain, Liver, Eyes, Heart, Kidney and Others) Veterinary Advanced Applications - Genomics (DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Biobanking: Applications - A Global Market Watch, 2009-2015   Axis Research Mind, Nov 2011, Pages: 656 application areas discussed in the report are: BY APPLICATIONS Stem Cells Blood Products Human (Tissue Sections, Brain, Liver, Eyes, Heart, Kidney and Others) Veterinary Advanced Applications - Genomics (DNA Results:  First -   Prev -   1 -   2 -   3 -   4 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network